Skip to main content

Table 1 Characteristics of cirrhotic patients with first esophageal variceal bleeding and mortality, Taiwan, 2005–2010

From: Effect of coexisting diabetes mellitus and chronic kidney disease on mortality of cirrhotic patients with esophageal variceal bleeding

 

42-day mortality

One-year mortality

 

Survivors (n = 699) (%)

Death (n = 189) (%)

p-value

Survivors (n = 488) (%)

Death (n = 400) (%)

p-value

Year of first diagnosis of EVB

      

 2005 (n = 167)

132 (18.9)

35 (18.5)

0.909

84 (17.2)

83 (20.8)

0.585

 2006 (n = 151)

122 (17.4)

29 (15.3)

0.808

84 (17.2)

67 (16.8)

0.864

 2007 (n = 142)

101 (14.4)

41 (21.7)

0.170

72 (14.8)

70 (17.5)

0.686

 2008 (n = 134)

102 (14.6)

32 (16.9)

0.769

79 (16.2)

55 (13.7)

0.729

 2009 (n = 146)

120 (17.2)

26 (13.8)

0.648

83 (17.0)

63 (15.7)

0.864

 2010 (n = 148)

122 (17.5)

26 (13.8)

0.615

86 (17.6)

62 (15.5)

0.793

Sex

      

 Female (n = 243)

202 (28.9)

41 (21.7)

0.049

151 (30.9)

92 (23.0)

0.008

Age at the first diagnosis of EVB

      

  < 50 (n = 261)

212 (30.3)

49 (25.9)

0.433

165 (33.8)

96 (24.0)

0.002

 50–69 (n = 437)

335 (47.9)

102 (54.0)

0.302

230 (47.1)

207 (51.8)

0.171

≥70 (n = 190)

152 (21.8)

38 (20.1)

0.626

93 (19.1)

97 (24.2)

0.061

Complication of cirrhosis

      

 HCC (n = 359)

247 (35.3)

112 (59.3)

<0.001

127 (26.0)

232 (58.0)

<0.001

 Infection during hospitalization (n = 58)

40 (5.7)

18 (9.5)

0.061

26 (5.3)

32 (8.0)

0.109

Previous episodes of decompensation required hospitalization within 1 year before EVB

      

Ascites

      

 0 (n = 711)

577 (82.6)

134 (70.9)

<0.001

417 (85.4)

294 (73.5)

<0.001

 1 (n = 114)

82 (11.7)

32 (16.9)

0.058

52 (10.7)

62 (15.5)

0.038

  ≥ 2 (n = 63)

40 (5.7)

23 (12.2)

0.002

19 (3.9)

44 (11.0)

<0.001

Hepatic encephalopathy

      

 0 (n = 789)

628 (89.9)

161 (85.2)

0.247

447 (91.6)

342 (85.4)

0.026

 1 (n = 60)

47 (6.7)

13 (6.9)

0.940

31 (6.4)

29 (7.3)

0.724

  ≥ 2 (n = 39)

24 (3.4)

15 (7.9)

0.041

10 (2.0)

29 (7.3)

0.001

SBP

      

 0 (n = 846)

670 (95.9)

176 (93.1)

0.329

477 (97.8)

369 (92.3)

<0.001

 1 (n = 35)

28 (4.0)

7 (3.7)

0.850

10 (2.0)

25 (6.2)

0.003

  ≥ 2 (n = 7)

1 (0.1)

6 (3.2)

<0.001

1 (0.2)

6 (1.5)

0.028

Etiology of cirrhosis

      

 HBV (n = 340)

250 (35.8)

90 (47.6)

0.003

168 (34.4)

172 (43.0)

0.009

 HCV (n = 306)

248 (35.5)

58 (30.7)

0.219

168 (34.4)

138 (34.5)

0.982

 Alcoholism (n = 382)

313 (44.8)

69 (36.5)

0.042

236 (48.4)

146 (36.5)

<0.001

Comorbidities

      

 DM (n = 332)

270 (38.6)

62 (32.8)

0.142

187 (38.3)

145 (36.3)

0.526

 CKD (n = 65)

43 (6.2)

22 (11.6)

0.010

23 (4.7)

42 (10.5)

0.001

 COPD (n = 216)

174 (24.9)

42 (22.2)

0.448

124 (25.4)

92 (23.0)

0.405

 Asthma (n = 87)

69 (9.9)

18 (9.5)

0.887

49 (10.0)

38 (9.5)

0.787

 TB (n = 28)

24 (3.4)

4 (2.1)

0.358

18 (3.7)

10 (2.5)

0.313

Previous episode of acute coronary syndrome (n = 184)

145 (20.7)

39 (20.6)

0.974

96 (19.7)

88 (22.0)

0.395

Previous episode of cerebrovascular accident (n = 102)

73 (10.4)

29 (15.3)

0.061

45 (9.2)

57 (14.3)

0.019

Low income

      

 Yes (n = 24)

20 (2.9)

4 (2.1)

0.575

7 (1.4)

17 (4.3)

0.010

Urbanization

      

 Urban (n = 438)

339 (48.5)

99 (52.4)

0.357

246 (50.4)

192 (48.0)

0.475

 Normal (n = 316)

243 (34.8)

73 (38.6)

0.357

160 (32.8)

156 (39.0)

0.120

 Rural (n = 134)

117 (16.7)

17 (9.0)

0.030

82 (16.8)

52 (13.0)

0.214

  1. CKD chronic kidney disease, COPD chronic obstructive pulmonary disease, DM diabetes mellitus, EVB esophageal variceal bleeding, HBV hepatitis B virus, HCC hepatocellular carcinoma, HCV hepatitis C virus, SBP spontaneous bacterial peritonitis, TB pulmonary tuberculosis